Biocon Ltd Deal Highlights
BIOCON Board approved ₹4,500 Cr QIP for cash portion; simplifies structure, eliminates holding discount, targets diabesity/oncology/immunology growth.
Leadership: Shreehas Tambe to lead combined entity; Siddharth Mittal transitions to group role.
#StockInNews
410 likes·33 comments